Delivery Order SPE2DB20D3103-SPE2DB22FN3D7
- Not listed
- This federal contract award is for the delivery of Sodium Chloride 0.9% Solution 100ML to the Defense Logistics Agency (DLA). The award, valued at $1,904.64, was made to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive...
- This federal contract award to Amerisourcebergen Drug Corp, valued at $2,067.70, is a Delivery Order issued by the Defense Logistics Agency (DLA) under the company's existing Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract is for the delivery of sodium chloride 0.9% solution in 100mL containers, a critical medical supply used in various healthcare settings. As an open competition award with no set-aside designation, Amerisourcebergen, a major pharmaceutical distributor...
- This federal contract award, valued at $1,841.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,962,460 units of 0.9% sodium chloride solution in 500ml containers. This is a firm fixed-price delivery order contract with an ultimate completion date of April 21, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $1,935.81 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 0.9% sodium chloride solution (100 mL) medical supplies. This Delivery Order contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical for a comprehensive range of pharmaceutical products and medical supplies...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,073.61 Firm Fixed Price delivery order contract is for the provision of 250ml Sodium Chloride 0.9% Solution, a common medical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award, valued at $3,928.05, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of sodium chloride 0.9% solution in 500 ml containers. The contract has a period of performance through December 8, 2023 and is a Firm Fixed Price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This contract award, valued at $1,133.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of sodium chloride 0.9% solution, 100ml, a critical medical supply. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $3,496.16, is for the delivery of Sodium Chloride 0.9% Solution 100mL, a common medical supply. This award is a delivery order under an Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for the company...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of sodium chloride 0.9% solution 100ml, a common medical supply, with a ceiling value of $1,481.82. This is a firm fixed price delivery order contract with a period of performance through March 27, 2025. The contract is not designated as a set-aside. Amerisourcebergen...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Sodium Chloride 0.9% Solution 100ML, a common medical product, with a ceiling value of $2,353.73 and a completion date of December 26, 2023. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FN3D7Delivery Order
This federal contract award, valued at $2,581.08, is a delivery order placed under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4556853220 - SODIUM CHLORIDE 0.9% SOLUTION 100ML, a common medical supply item. The IDC with Amerisourcebergen Drug Corp is a single-award contract valued up to $999,999,999.00 and runs through November 2026. This vehicle enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The contract award did not have any set-aside designations, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that has established itself as a key vendor for various federal agencies, particularly the DLA and Department of Justice, providing essential medical commodities across numerous therapeutic areas.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 4/11/22 |